Cargando…

Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32

Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Kohji, Imura, Johji, Shimomura, Akiko, Noguchi, Akira, Minamisaka, Takashi, Tanaka, Shinichi, Nishida, Takeshi, Hatta, Hideki, Nakajima, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400074/
https://www.ncbi.nlm.nih.gov/pubmed/32782605
http://dx.doi.org/10.3892/ol.2020.11825
_version_ 1783566279801569280
author Takagi, Kohji
Imura, Johji
Shimomura, Akiko
Noguchi, Akira
Minamisaka, Takashi
Tanaka, Shinichi
Nishida, Takeshi
Hatta, Hideki
Nakajima, Takahiko
author_facet Takagi, Kohji
Imura, Johji
Shimomura, Akiko
Noguchi, Akira
Minamisaka, Takashi
Tanaka, Shinichi
Nishida, Takeshi
Hatta, Hideki
Nakajima, Takahiko
author_sort Takagi, Kohji
collection PubMed
description Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients with pancreatic cancer. Therefore, in order to elucidate the factors that contribute to this high invasiveness, a selective invasion method was used to establish four highly invasive subclones from six human pancreatic cancer cell lines. The results demonstrated that two cell lines did not exhibit enhanced invasiveness. Microarray analysis revealed that, in the highly invasive cell lines, several genes were expressed at high levels, compared with the original cell lines. These highly expressed genes were recognized only in highly invasive cells. Among them, IL-32 was most strongly upregulated in the highly invasive cells, compared with cells with a low invasive potential, as well as the original cells. RT-qPCR and western blot analysis confirmed the high levels of expression of IL-32 in highly invasive cells at the RNA and protein levels. In addition, immunohistochemical analysis of resected surgical materials revealed that the tumor cells expressed IL-32 and, in particular, many IL-32 positive cells were seen at the invasive front of the tumor tissue. IL-32 is a cytokine that is widely involved in the development of cancer and has recently received considerable attention. This cytokine has multiple splice variants and shows a wide variety of behaviors, depending on the tumor type and primary organ. Although some hypotheses have been proposed to explain the activity of IL-32, a unified view has not been agreed. In the present study, through the establishment of highly invasive cells from pancreatic cancer and a comprehensive gene analysis, it is suggested that IL-32 may serve an important role as a molecule involved in the invasiveness of this neoplasm.
format Online
Article
Text
id pubmed-7400074
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74000742020-08-10 Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32 Takagi, Kohji Imura, Johji Shimomura, Akiko Noguchi, Akira Minamisaka, Takashi Tanaka, Shinichi Nishida, Takeshi Hatta, Hideki Nakajima, Takahiko Oncol Lett Articles Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients with pancreatic cancer. Therefore, in order to elucidate the factors that contribute to this high invasiveness, a selective invasion method was used to establish four highly invasive subclones from six human pancreatic cancer cell lines. The results demonstrated that two cell lines did not exhibit enhanced invasiveness. Microarray analysis revealed that, in the highly invasive cell lines, several genes were expressed at high levels, compared with the original cell lines. These highly expressed genes were recognized only in highly invasive cells. Among them, IL-32 was most strongly upregulated in the highly invasive cells, compared with cells with a low invasive potential, as well as the original cells. RT-qPCR and western blot analysis confirmed the high levels of expression of IL-32 in highly invasive cells at the RNA and protein levels. In addition, immunohistochemical analysis of resected surgical materials revealed that the tumor cells expressed IL-32 and, in particular, many IL-32 positive cells were seen at the invasive front of the tumor tissue. IL-32 is a cytokine that is widely involved in the development of cancer and has recently received considerable attention. This cytokine has multiple splice variants and shows a wide variety of behaviors, depending on the tumor type and primary organ. Although some hypotheses have been proposed to explain the activity of IL-32, a unified view has not been agreed. In the present study, through the establishment of highly invasive cells from pancreatic cancer and a comprehensive gene analysis, it is suggested that IL-32 may serve an important role as a molecule involved in the invasiveness of this neoplasm. D.A. Spandidos 2020-09 2020-07-08 /pmc/articles/PMC7400074/ /pubmed/32782605 http://dx.doi.org/10.3892/ol.2020.11825 Text en Copyright: © Takagi et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Takagi, Kohji
Imura, Johji
Shimomura, Akiko
Noguchi, Akira
Minamisaka, Takashi
Tanaka, Shinichi
Nishida, Takeshi
Hatta, Hideki
Nakajima, Takahiko
Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title_full Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title_fullStr Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title_full_unstemmed Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title_short Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
title_sort establishment of highly invasive pancreatic cancer cell lines and the expression of il-32
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400074/
https://www.ncbi.nlm.nih.gov/pubmed/32782605
http://dx.doi.org/10.3892/ol.2020.11825
work_keys_str_mv AT takagikohji establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT imurajohji establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT shimomuraakiko establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT noguchiakira establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT minamisakatakashi establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT tanakashinichi establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT nishidatakeshi establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT hattahideki establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32
AT nakajimatakahiko establishmentofhighlyinvasivepancreaticcancercelllinesandtheexpressionofil32